Integrating value chains to improve food safety and increase smallholder incomes in Kenya
Last registered on December 19, 2018

Pre-Trial

Trial Information
General Information
Title
Integrating value chains to improve food safety and increase smallholder incomes in Kenya
RCT ID
AEARCTR-0001373
Initial registration date
June 23, 2016
Last updated
December 19, 2018 7:49 AM EST
Location(s)
Primary Investigator
Affiliation
IFPRI
Other Primary Investigator(s)
PI Affiliation
Wageningen University
PI Affiliation
Wageningen University
PI Affiliation
Wageningen University
PI Affiliation
Wageningen University
Additional Trial Information
Status
Completed
Start date
2017-04-03
End date
2018-07-31
Secondary IDs
Abstract
Adoption of improved agricultural technologies in developing countries may be limited by common informational and market inefficiencies. In this study, we examine the role of such inefficiencies in the adoption of a new food safety technology, Aflasafe. Aflasafe has been shown to reduce aflatoxin contamination in maize by approximately 90%. However, this technology faces several barriers to widespread adoption. First, since Aflasafe is applied while the crop is still growing, its use increases farmers’ exposure to yield risk. In the absence of a market for crop insurance, this may limit its adoption. Second, the lack of price incentives for food safety in markets served by smallholder maize producers in Kenya may constrain the adoption of food safety technologies by these farmers. In this study, we explore the impact on adoption of Aflasafe of 1) bundling the product with a rainfall index based money-back guarantee, and 2) access to an output market that rewards aflatoxin safety.
External Link(s)
Registration Citation
Citation
Bulte, Erwin et al. 2018. "Integrating value chains to improve food safety and increase smallholder incomes in Kenya." AEA RCT Registry. December 19. https://www.socialscienceregistry.org/trials/1373/history/39173
Sponsors & Partners

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information
Experimental Details
Interventions
Intervention(s)
The study will include 3 interventions: an Input Linkage treatment, a Money Back Guarantee treatment and an Output Market Linkage treatment. The Input Linkage treatment groups will receive information on the benefits of Aflasafe and instruction on its use. They will also be given an opportunity to buy Aflasafe, which is not currently available in the study area. These groups will further be divided into two treatment conditions concerning money back guarantee (MBG): an Optional condition, offered the option to buy Aflasafe either with or without the MBG, and a Bundled condition, in which Aflasafe is only offered in combination with the MBG. The Money Back Guarantee treatment will be crossed with the Output Market Linkage treatment, which consists of a linkage between the farmer group and a buyer that pays a premium for safe maize. Hence, in total there will be five categories, including the pure control group, and four treatment groups (Optional MBG / Output linkage , Optional MBG / No output linkage, Bundled MBG / Output linkage, and Bundled MBG / No output linkage).
Intervention Start Date
2017-09-11
Intervention End Date
2018-07-31
Primary Outcomes
Primary Outcomes (end points)
1. Adoption of Aflasafe during the 2017 season
2. Relative level of Aflasafe application to / aflatoxin levels in maize stored by households for different purposes
Primary Outcomes (explanation)
1. Adoption of Aflasafe
Farmers’ adoption decisions will be measured by a dummy variable, equal to 1 if the farmer adopted and 0 if the farmer did not adopt. The intensity of adoption will be measured as the amount of Aflasafe purchased. Both the binary and intensity adoption variables will be constructed using Aflasafe sales data.

2. Aflatoxin contamination and Aflasafe usage:
Samples of maize will be taken from the following three sources:
1) Maize stored for household consumption
2) Maize stored for later sale
3) Maize aggregated for testing and sale through the study
Samples will be tested for aflatoxin using a quantitative test with an upper detection limit of 150 ppb. In the event that more than 5% of samples are at or above the upper limit of the detection range, these will be diluted and re-analyzed, to a maximum detection level of 400. A microbiological test will be used to assess whether Aflasafe was used on a batch of maize. Selection of one or both aflatoxin contamination and/or Aflasafe usage depends on the relative costs and efficiency of these two indicators for assessing farmer behavior.
Secondary Outcomes
Secondary Outcomes (end points)
Secondary Outcomes (explanation)
Experimental Design
Experimental Design
Farmer groups are drawn from a list of 250 farmer groups obtained from the Cereal Growers Association and county Ministries of Agriculture. Based on power calculations, we allocated 160 farmer groups across the four treatment groups and the control group as follows: Optional MBG / Output linkage: 38, Optional MBG / No output linkage: 38, Bundled MBG / Output linkage: 38, and Bundled MBG / No output linkage: 38; Pure Control: 8.
In order to limit spillovers across money back guarantee treatments, we created comparable, but geographically distinct, clusters of farmer groups within each of the study counties (4 in Meru, 2 in Tharaka-Nithi and 2 in Embu) and subsequently assigned these clusters to either the bundled or the optional MBG treatment. Subject to a minimum geographical distance of 5 km between clusters, we aimed to select similar farmer groups into the clusters within each county. Similarity was defined based on the Euclidean distance in the six-dimensional space formed by the standardized values of variables listed in section 5.4.
To this end, we first dropped clusters close to the county borders to achieve a minimum distance of groups in different counties of at least 5 km. Subsequently, we excluded any groups within a 5 km bands dividing the remaining groups into similarly-sized clusters. The direction of this band was selected to minimize the Euclidean distance between the groups on either side of it. From the remaining groups, we then iteratively selected matched pairs across each cluster with the lowest Euclidean distance into the sample. To ensure that the MBG treatments were spread out geographically, we manually decided which clusters would receive the same treatment. Finally, we randomly assigned the bundled MBG to one of the two groups of clusters.
Within each of the money back guarantee clusters, the market linkage treatment was randomly assigned at the village level.
Pure control groups were selected as the 8 nearest geographical neighbors to any BY group, stratified by county approximately in proportion to the total number of groups on the initial list.
Experimental Design Details
Randomization Method
Randomization done in office by a computer
Randomization Unit
village
Was the treatment clustered?
Yes
Experiment Characteristics
Sample size: planned number of clusters
160 farmer groups (cluster for data collection) across 124 villages (level of randomization)
Sample size: planned number of observations
960 farmers for baseline and follow-up surveys (6 per farmer group); approximately 4000 total farmers in the groups (average of 25 / group)
Sample size (or number of clusters) by treatment arms
Optional MBG / Output linkage: 38 farmer groups
Optional MBG / No output linkage: 38 farmer groups
Bundled MBG / Output linkage: 38 farmer groups
Bundled MBG / No output linkage: 38 farmer groups
Pure Control: 8 farmer groups
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB
INSTITUTIONAL REVIEW BOARDS (IRBs)
IRB Name
International Food Policy Research Institute Institutional Review Board
IRB Approval Date
2016-05-16
IRB Approval Number
2016-26-MTID-M
IRB Name
AMREF Kenya Ethics and Scientific Review Committee
IRB Approval Date
2016-10-04
IRB Approval Number
n/a
IRB Name
Human Subjects Committee for Innovations for Poverty Action IRB-USA
IRB Approval Date
2016-05-11
IRB Approval Number
14154
Analysis Plan
Analysis Plan Documents
pre-analysis plan

MD5: 1048413f43e36e951c25efdbec63302d

SHA1: 6d3f5a06ab732934d2f964d538913247ad34c98c

Uploaded At: November 09, 2017

Post-Trial
Post Trial Information
Study Withdrawal
Intervention
Is the intervention completed?
No
Is data collection complete?
Data Publication
Data Publication
Is public data available?
No
Program Files
Program Files
Reports and Papers
Preliminary Reports
Relevant Papers